Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.55 HKD | -0.92% | +8.40% | +5.38% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
Business Summary
Number of employees: 115,959
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Distribution
71.0
%
| 454,485 | 72.4 % | 455,592 | 71.0 % | +0.24% |
Medical Devices
21.7
%
| 129,455 | 20.6 % | 139,088 | 21.7 % | +7.44% |
Retail Pharmacy
5.9
%
| 34,438 | 5.5 % | 37,681 | 5.9 % | +9.42% |
Other
1.5
%
| 9,599 | 1.5 % | 9,720 | 1.5 % | +1.27% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 627,977 | 100.0 % | 642,080 | 100.0 % | +2.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yong Liu
PSD | President | 55 | 09-01-08 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 55 | 11-02-28 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 59 | 10-04-30 |
Guang Fu Li
PRN | Corporate Officer/Principal | 66 | 10-04-30 |
Jun Lu
PRN | Corporate Officer/Principal | 66 | 04-06-28 |
Yi Jian Wu
SEC | Corporate Secretary | 54 | - |
Xiu Chang Jiang
PRN | Corporate Officer/Principal | 60 | 10-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 10-04-30 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 19-01-10 |
Yi Jian Wu
SEC | Corporate Secretary | 54 | - |
Pei Yu Li
BRD | Director/Board Member | 61 | 20-09-17 |
De Yong Wen
BRD | Director/Board Member | 52 | 17-08-31 |
Kan Wang
BRD | Director/Board Member | 39 | 22-12-22 |
Fang Ruo Chen
BRD | Director/Board Member | 59 | 19-01-10 |
Rong Li Feng
BRD | Director/Board Member | 49 | 20-06-10 |
Sheng Hao Shi
BRD | Director/Board Member | 55 | 23-06-14 |
Peng Wang
BRD | Director/Board Member | 42 | 22-12-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,778,845,451 | 0 | 0 | 42.99 % |
Stock B | 1 | 1,341,810,740 | 1,341,651,731 ( 99.99 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
304,842,487 | 63.77% | 1,295,720,797 $ | |
201,156,574 | 100.00% | 918,466,836 $ | |
19,068,440 | 1.42% | 23,586,707 $ |
Company contact information
Sinopharm Group Co., Ltd.
Sinopharm Group Building No. 385, East Longhua Road
200023, Shanghai
+86 21 2305 2666
http://ir.sinopharmgroup.com.cnSector
Sales per Business
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.38% | 8.67B | |
+16.62% | 70.95B | |
+2.99% | 25.25B | |
+6.46% | 8.16B | |
-21.01% | 7.91B | |
+0.49% | 4.51B | |
+17.12% | 4.31B | |
-0.14% | 4.07B | |
-3.57% | 3.84B | |
+21.70% | 3.63B |
- Stock Market
- Equities
- 1099 Stock
- Company Sinopharm Group Co. Ltd.